First clinical experience using a ‘pathotropic’ injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer. - Gordon,E.M.; Cornelio,G.H.; Lorenzo,C.C. (Int J Oncol, 2004)